| Group 1 | Group 2 | |
| Non-Q-wave-MI | 104 (28.6 ± 2.4) | 69 (20.7 ± 2.2) |
| Q-wave-MI | 259 (71.4 ± 2.4) | 265 (79.3 ± 2.2) |
| Localization | ||
| Anterior MI | 172 (47.4 ± 2.6) | 171 (51.2 ± 2.7) |
| Inferior MI | 191 (52.6 ± 2.6) | 163 (48.8 ± 2.7) |
| Myocardial revascularization, including: | 138 (38.0 ± 2.6) | 141(42.2 ± 2.7) |
| Coronary artery bypass surgery | 49 (13.5 ± 1.8) | 49 (14.7 ± 1.9) |
| Stenting | 33 (9.1 ± 1.5) | 62 (18.6 ± 2.1) |
| Thrombolysis | 65 (17.9 ± 2.0) | 72 (21.6 ± 2.3) |
| Concomitant pathology | ||
| Arterial hypertension | 242 (66.7 ± 2.5) | 214 (64.1 ± 2.6) |
| Diabetes mellitus | 59 (16.3 ± 1.9) | 44 (13.2 ± 1.9) |
| Dislipidemia | 212 (58.4 ± 2.6) | 230 (68.9 ± 2.5) |